Cancer-related deaths in India are projected to go up by 20% over the next four years.
Shukrit Sudhir Chimote
Chief Executive Officer, Sayre Therapeutics
Shukrit&amp;nbsp;has had a proven track record in the Pharmaceutical Industry and prior to co-founding Sayre Therapeutics, he served as Vice-President and India &amp;amp; South Asia Head, Branded Formulations at a premier Indian biotech. In his earlier roles at the Indian biotech, he has headed the Novel Medicines out-licensing and Biosimilars’ strategic business units. Prior to this role,&amp;nbsp;Shukrit&amp;nbsp;was employed with Bristol-Myers Squibb, Princeton, NJ, US in roles within the Anti-infectives, Cardiology and Immunology franchises. He was part of the global marketing team where he conceptualized the go-to-market strategies for Japan, China, Singapore and Indian markets, among other Asia-Pacific markets. Shukrit&amp;nbsp;completed his Bachelor’s degree in Pharmacy from Mumbai, India and his MS in Pharmacology &amp;amp; an MBA in Pharmaceutical Marketing from the University of Mississippi, US. He also has a Masters in International affairs from the Columbia University, New York.
SIGN UP FOR THE DAILY BRIEF FROM HUFFPOST INDIA
Get our top news delivered to your inbox every morning, Monday to Friday. Newsletters may offer personalized content or advertisements. Learn more